Iridoid glycosides fraction of folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Liu, Xin ^a   Wang, Jian Ming ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; DEXTRAN SULFATE; FAS ANTIGEN; FAS LIGAND; FOLIUM SYRINGAE EXTRACT; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; IRIDOID; MESSENGER RNA; MYELOPEROXIDASE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DOWN REGULATION; DRUG ISOLATION; DRUG TARGETING; ENZYME ACTIVITY; FOLIUM SYRINGAE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; MALE; MEDICINAL PLANT; NICK END LABELING; NONHUMAN; PLANT LEAF; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE STUDY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; SPRAGUE DAWLEY RAT; SYRINGA;

RATTUS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COLITIS, ULCERATIVE; DEXTRAN SULFATE; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; IRIDOID GLUCOSIDES; MALE; NF-KAPPA B; PEROXIDASE; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYRINGA;

EID: 80052783370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024740     Document Type: Article

References (58)

1. Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, et al. (2008) Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc Natl Acad Sci USA 105: 15058-15063.
2. Shanahan F, Bernstein CN, (2009) The evolving epidemiology of inflammatory bowel disease. Curr Opin in Castroenterol 25: 301-305.
3. Jun CD, Kim Y, Choi EY, Kim M, Park B, et al. (2006) Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-κB pathway in vitro and in vivo. Inflamm Bowel Dis 12: 619-629.
4. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, et al. (2006) Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 12: 1152-1161.
5. Kozuch PL, Hanauer SB, (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14: 354-377.
6. Seidelin JB, Nielsen OH, (2008) Attenuated Apoptosis Response to Fas-ligand in Active Ulcerative Colitis. Inflamm Bowel Dis 14: 1623-1629.
7. Martin AR, Villegas I, Sanchez-Hidalgo M, de la Lastra CA, (2006) The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Brit J Pharmacol 147: 873-885.
8. Da Silva MS, Sánchez-Fidalgo S, Talero E, Cárdeno A, da Silva MA, et al. (2010) Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model. J Ethnopharmacol 128: 467-475.
9. O'Shea J, Ma A, Lipsky P, (2002) Cytokines and autoimmunity. Nat Rev 2: 37-45.
10. Lammers KM, Vergopoulos A, Babel N, Rizzello F, Morselli C, et al. (2005) Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1β, interleukin-8 and interferon-γ gene expression. Inflamm Bowel Dis 11: 447-454.
11. Yao J, Wang JY, Liu L, Li YX, Xun AY, et al. (2010) Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis. Arch Med Res 41: 288-294.
12. Talero E, Sanchez-Fidalgo S, Alarcon de la Lastra C, Illanes M, Calvo JR, et al. (2008) Acute and chronic responses associated with adrenomedullin administration in experimental colitis. Peptides 29: 2001-2012.
13. Seidelin JB, Nielsen OH, (2003) Apoptosis in chronic inflammatory bowel disease. The importance for pathogenesis and treatment. Ugeskr Laeger 165: 790-792.
14. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, et al. (1997) CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113: 160-167.
15. Nagata S, (1997) Apoptosis by death factor. Cell 88: 355-365.
16. Clavel T, Haller D, (2007) Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13: 1153-1164.
17. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
18. Beck PL, Rosenberg IM, Xavier RJ, Koh T, Wong JF, et al. (2003) Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol 162: 597-608.
19. Sakuraba H, Ishiguro Y, Yamagata K, Munakata A, Nakane A, (2007) Blockade of TGF-β accelerates mucosal destruction through epithelial cell apoptosis. Biochem Biophys Res Commun 359: 406-412.
20. Kilic ZM, Ayaz S, Özin Y, Nadir I, Cakal B, et al. (2009) Plasma transforming growth factor-β1 level in inflammatory bowel disease. Turk J Gastroenterol 20: 165-170.
21. Lee KY, Ito K, Hayashi R, Jazrawi EP, Barnes PJ, et al. (2006) NF-κB and Activator Protein 1 Response Elements and the Role of Histone Modifications in IL-β1-Induced TGF-β1 Gene Transcription. J Immunol 176: 603-615.
22. Wiercińska-Drapalo A, Flisiak R, Prokopowicz D, (2003) Effect of ulcerative colitis treatment on transforming growth factor β1 in plasma and rectal mucosa. Regul Peptides 113: 57-61.
23. Chae S, Eckmann L, Miyamoto Y, Pothoulakis C, Karin M, et al. (2006) Epithelial cell IκB-Kinase β has an important protective role in clostridium difficile toxin A-induced mucosal injury. J Immunol 177: 1214-1220.
24. Zhang DK, He FQ, Li TK, Pang XH, Cui de J, et al. (2010) Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis. J Pathol 22: 213-222.
25. Fiocchi C, (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
26. Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, Strober W, (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 9: 998-1004.
27. Ghosh S, Karin M, (2002) Missing pieces in the NF-κB puzzle. Cell 109: 81-96.
28. Hayden MS, Ghosh S, (2008) Shared Principles in NF-κB Signaling. Cell 132: 344-362.
29. Lee JY, Kim JS, Kim JM, Kim N, Jung HC, et al. (2007) Simvastatin inhibits NF-κB signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int Immunopharmacol 7: 241-248.
30. Malek R, Borowicz KK, Jargiello M, Czuczwar SJ, (2007) Role of NF-κB in the central nervous system. Pharmacol Rep 59: 25-33.
31. Atreya I, Atreya R, Neurath MF, (2008) NF-κB in inflammatory bowel disease. J Intern Med 263: 591-596.
32. Liu X, Wang J, Zhou C, Gan L, (2010) Preparative separation and enrichment of syringopicroside from Folium syringae leaves with macroporous resins. J Biomed Biotechnol accepted 28 November 2010, Article ID 572570, doi:10.1155/2010/572570.
33. Liu X, Wang JM, (2011) Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J Ethnopharmacol 133: 780-787.
34. Cooper HS, Murthy SN, Shah RS, Sedergran DJ, (1993) Clinicopathlolgic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249.
35. Wallace JL, Keenan CM, Gale D, Shoupe TS, (1992) Exacerbation of experimental colitis by non-steroidal antinflammatory drugs is not related to elevate leukotriene B4 synthesis. Gastroenterology 102: 18-27.
36. Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, et al. (2001) Effects of tumor necrosis factor-α synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol 421: 103-110.
37. Krawisz JE, Sharon P, Stenson WF, (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350.
38. Mazzon E, Esposito E, Crisafulli C, Riccardi L, Muià C, et al. (2006) Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. J Pineal Res 41: 363-373.
39. Nam SY, Kim JS, Kim JM, Lee JY, Kim N, et al. (2008) DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood) 233: 180-191.
40. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, et al. (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306.
41. Yang F, Tang E, Guan K, Wang CY, (2003) IKKbeta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170: 5630-5635.
42. Malinin NL, Boldin MP, Kovalenko AV, Wallach D, (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
43. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, et al. (1999) Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163: 3474-3483.
44. Hayden MS, Ghosh S, (2004) Signaling to NF-κB. Genes Dev 18: 2195-2224.
45. Kucharczak J, Simmons MJ, Fan Y, Gélinas C, (2003) To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22: 8961-8982.
46. Ueyama H, Kiyohara T, Sawada N, Isozaki K, Kitamura S, et al. (1998) High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 43: 48-55.
47. Sayani FA, Keenan CM, Van Sickle MD, Amundson KR, Parr EJ, et al. (2004) The expression and role of Fas ligand in intestinal inflammation. Neurogastroenterol Motil 16: 61-74.
48. Barnhart BC, Pietras EM, Geciras-Schimnich A, Salmena L, Sayama K, et al. (2005) CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8. Cell Death Differ 12: 25-37.
49. Scorrano L, Korsmeyer SJ, (2003) Mechanisms of cytochrome C release by proapoptotic Bcl-2 family members. Biochem Biophys Res Commun 304: 437-444.
50. Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, et al. (1999) Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 63: 1081-1090.
51. Stadnicki A, Machnik G, Klimacka-Nawrot E, Wolanska-Karut A, Labuzek K, (2009) Transforming growth factor-β1 and its receptors in patients with ulcerative colitis. Int Immunopharmacol 9: 761-766.
52. Kilic ZMY, Ayaz S, Özin Y, Nadir I, Cakal B, et al. (2009) Plasma transforming growth factor-β1 level in inflammatory bowel disease. Turk J Gastroenterol 20: 165-170.
53. Koelink PJ, Hawinkels LJ, Wiercinska E, Sier CF, ten Dijke P, et al. (2010) 5-Aminosalicylic acid inhibits TGF-β1 signalling in colorectal cancer cells. Cancer Lett 287: 82-90.
54. Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM, (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia 59: 242-255.
55. Luo JL, Kamata H, Karin M, (2005) IKK/NF-κB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115: 2625-2632.
56. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, et al. (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
57. Weber CK, Liptay S, Wirth T, Adler G, Schmid RM, (2000) Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β. Gastroenterology 119: 1209-1218.
58. Zhang LX, (2009) The research progress of Folium syringae leaves. Strait Pharmaceutical Journal 21: 20-23.